CARLY SINGLETARY: Open Payments
NPI 1649835638 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,623 in 46 payments from 14 companies in 2025. Trend: 2023 $1,475 · 2024 $1,872 · 2025 $1,623
Food & beverage: $1,623
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 10 | $321 |
| Organon LLC | 3 | $252 |
| UCB, Inc. | 12 | $216 |
| Botanix SB Inc | 2 | $152 |
| GENZYME CORPORATION | 4 | $150 |
| ABBVIE INC. | 2 | $148 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $65 |
| Galderma Laboratories, L.P. | 3 | $47 |
| Janssen Biotech, Inc. | 2 | $37 |
Products named: Zoryve, VTAMA, Bimzelx, DUPIXENT, TREMFYA, SOFDRA, RINVOQ, Leqselvi.
Industry payments across GA — which companies pay providers there.
